CDK7 and glioblastoma: Here, we report that the covalent CDK7 inhibitor, THZ14, 5 suppresses GBM proliferation by impairing mitochondrial function and activating the unfolded protein response (UPR), resulting in autophagy and non‐apoptotic cell death, characterised by features consistent with methuosis.6